반응식
O[C:2]1[CH:3]=[C:4]([NH:8][C:9]2[N:14]=[C:13]([NH:15][C:16]3[CH:21]=[CH:20][CH:19]=[C:18](O)[CH:17]=3)[C:12]([F:23])=[CH:11][N:10]=2)[CH:5]=[CH:6][CH:7]=1.[CH2:24]([N:31]1[CH2:36][CH2:35][N:34](C2C=CC(N)=CC=2)[CH2:33][CH2:32]1)[C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1.Cl[C:45]1[N:50]=[C:49](Cl)[C:48](F)=[CH:47]N=1>>[CH2:49]([N:50]1[CH2:45][CH2:9][N:8]([C:7]2[CH:6]=[CH:5][C:4]([NH:8][C:9]3[N:14]=[C:13]([NH:15][C:16]4[CH:21]=[CH:20][C:19]([N:34]5[CH2:33][CH2:32][N:31]([CH2:24][C:25]6[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=6)[CH2:36][CH2:35]5)=[CH:18][CH:17]=4)[C:12]([F:23])=[CH:11][N:10]=3)=[CH:3][CH:2]=2)[CH2:4][CH2:3]1)[C:48]1[CH:47]=[CH:2][CH:7]=[CH:6][CH:5]=1참가 물질
4
실험 절차
In a manner analogous to the preparation of N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine, the reaction of 4-(N-benzylpiperazino)aniline (400 mg, 1.5 mmol) and 2,4-dichloro-5-fluoropyrimidine (50 mg, 0.3 mmol) resulted N2,N4-bis[4-(N-benzylpiperazino)phenyl]-5-fluoro-2,4-pyrimidinediamine (120 mg, 64%). 1H NMR (CDCl3): δ 2.63 (p, J=2.4 Hz, 8 H), 3.14 (t, J=4.8 Hz, 4 H), 3.19 (t, J=4.8 Hz, 4 H), 3.58 (s, 4 H), 6.58 (d, 1 H, NH), 6.67 (br, 1 H, NH), 6.87 (d, J=9.3 Hz, 2 H), 6.90 (d, J=9.0 Hz, 2 H), 7.33-7.39 (m, 12 H), 7.46 (d, J=9.0 Hz, 2 H), 7.87 (d, J=3.3 Hz, 1 H); 19F NMR (282 MHz, CDCl3): δ−169.06; LCMS: 16.82 min.; purity: 96.88%; MS (m/e): 629.12 (MH+).
출처 및 근거
- ORD 기록
- ord-f9fb87d260094f9f8d4460f35b74893f
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08822685B2
연결된 노트
불러오는 중…